Top Page
Cannabist Company Holdings
(NEO-L:CBST)
Cannabist Company Holdings (CBST) vs. iShares MSCI Canada ETF (EWC)
Cannabist Company Holdings Business Overview & Revenue Model
Cannabist Company Holdings Earnings Call Summary
Cannabist Company Holdings Financial Statement Overview
| Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 458.72M | 511.33M | 491.31M | 456.03M | 188.99M |
| Gross Profit | 168.30M | 179.97M | 136.13M | 146.92M | 52.68M |
| EBITDA | 28.61M | -51.30M | -282.36M | -63.14M | -115.66M |
| Net Income | -105.89M | -175.71M | -399.52M | -141.84M | -100.85M |
Balance Sheet | |||||
| Total Assets | 696.17M | 823.11M | 994.28M | 1.37B | 727.53M |
| Cash, Cash Equivalents and Short-Term Investments | 33.61M | 36.91M | 48.13M | 82.09M | 61.11M |
| Total Debt | 478.42M | 546.32M | 566.97M | 420.75M | 295.21M |
| Total Liabilities | 726.23M | 757.76M | 787.47M | 824.57M | 440.58M |
| Stockholders Equity | -28.69M | 66.53M | 213.19M | 570.62M | 306.82M |
Cash Flow | |||||
| Free Cash Flow | -29.21M | -2.50M | -179.70M | -132.64M | -97.42M |
| Operating Cash Flow | -23.38M | 7.47M | -106.99M | -518.40K | -52.27M |
| Investing Cash Flow | 30.98M | -3.50M | -72.34M | -189.67M | -24.02M |
| Financing Cash Flow | -9.00M | -14.12M | 147.59M | 200.66M | 90.00M |
Cannabist Company Holdings Technical Analysis
Cannabist Company Holdings Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | €6.37B | 19.48 | -1.30% | 2.24% | -0.16% | -45.39% | |
39 Underperform | $227.80M | ― | -554.70% | ― | -14.45% | 44.87% | |
| ― | $229.78M | ― | -122.10% | ― | ― | ― | |
| ― | $195.95M | 21.32 | 4.76% | ― | ― | ― | |
| ― | $250.99M | 95.99 | 3.05% | ― | ― | ― | |
| ― | $140.98M | 8.49 | 18.60% | ― | ― | ― | |
58 Neutral | C$170.20M | ― | -38.89% | ― | -6.80% | 11.94% |
Cannabist Company Holdings Corporate Events
The Cannabist Company announced it will release its second-quarter 2025 financial results on August 7, 2025, before U.S. markets open, followed by a conference call. This announcement is significant for stakeholders as it provides insights into the company’s financial health and operational performance, potentially influencing its market position and investor confidence.
The most recent analyst rating on (TSE:CBST) stock is a Buy with a C$0.70 price target. To see the full list of analyst forecasts on Cannabist Company Holdings stock, see the TSE:CBST Stock Forecast page.
The Cannabist Company Holdings Inc. has successfully completed a court-approved plan of arrangement, which involved exchanging existing senior secured notes for new senior notes due in 2028 and issuing new common shares and warrants to stakeholders. This strategic financial restructuring aims to enhance the company’s financial stability and operational flexibility, potentially strengthening its market position in the competitive cannabis industry.
The most recent analyst rating on (TSE:CBST) stock is a Hold with a C$0.10 price target. To see the full list of analyst forecasts on Cannabist Company Holdings stock, see the TSE:CBST Stock Forecast page.
The Cannabist Company Holdings Inc. announced it has received court approval for its previously announced plan of arrangement under the Canada Business Corporations Act. This approval marks a significant step forward for the company, with the closing date targeted for May 29, 2025, pending regulatory approvals. The arrangement involves the issuance of new warrants to shareholders and is expected to impact the company’s operational structure and market positioning, enhancing its ability to deliver products and services across its network.
The most recent analyst rating on (TSE:CBST) stock is a Hold with a C$0.10 price target. To see the full list of analyst forecasts on Cannabist Company Holdings stock, see the TSE:CBST Stock Forecast page.
The Cannabist Company reported a decrease in revenue for the first quarter of 2025, attributed to strategic closures and sales of underperforming locations. Despite the revenue drop, the company improved its gross margin and adjusted EBITDA margin through cost reduction and operational optimization. The company is undergoing a debt restructuring process and plans to further streamline its operations by divesting assets in Florida, California, and Illinois. The focus remains on liquidity, balance sheet management, and expanding retail operations in key markets.
The Cannabist Company reported a decrease in revenue for the first quarter of 2025, attributed to strategic closures and divestitures aimed at simplifying operations and improving margins. The company is focusing on liquidity and operational improvements, with plans to open new retail locations in Ohio and Virginia, while preparing for the transition to adult use in Delaware. The approval of a debt restructuring transaction by Senior Note holders marks a significant step towards financial stability, pending court approval in Canada.
The Cannabist Company has received approval from its senior noteholders for a plan of arrangement that involves exchanging existing senior notes for new ones due in 2028 and issuing new common shares and warrants. This approval, which surpassed the required two-thirds majority, marks a significant step for the company, although the arrangement still requires court approval and faces opposition from a holder of the 2025 notes. The outcome of this arrangement could impact the company’s financial restructuring and its position in the cannabis industry.
The Cannabist Company has announced the launch of adult-use cannabis sales at its Mays Landing dispensary in New Jersey, marking its third location in the state. This expansion strengthens the company’s retail presence and supports its commitment to providing high-quality cannabis products to both medical and adult-use consumers. The grand opening event will feature promotions and a guest appearance by Ric Flair, enhancing community engagement and brand visibility. The company’s recent upgrades to its Vineland facilities further bolster its capacity to meet growing demand, positioning it favorably in the competitive cannabis market.